These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3621671)

  • 1. Anti-oestrogen antibodies in users of oral contraceptives and in patients with systemic lupus erythematosus.
    Bucala R; Lahita RG; Fishman J; Cerami A
    Clin Exp Immunol; 1987 Jan; 67(1):167-75. PubMed ID: 3621671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of 16 alpha-hydroxyestrone-modified proteins in pregnancy and in systemic lupus erythematosus.
    Bucala R; Lahita RG; Fishman J; Cerami A
    J Clin Endocrinol Metab; 1985 May; 60(5):841-7. PubMed ID: 3920233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiestrogen antibodies, oral contraception and systemic lupus erythematosus.
    Beaumont V; Gioud-Paquet M; Kahn MF; Beaumont JL
    Clin Physiol Biochem; 1989; 7(5):263-8. PubMed ID: 2805575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary hypertension, systemic lupus erythematosus, and the contraceptive pill: another report.
    Miller MH
    Ann Rheum Dis; 1987 Feb; 46(2):159-61. PubMed ID: 3827339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid function tests under the effect of steroidal contraceptives compared to normal pregnancy.
    Nasr EM; El-mekkawi T; Abbas A; El-sheikha Z; Abdel Aziz A
    Popul Sci; 1982; (3):157-68. PubMed ID: 12266214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptive therapy and systemic lupus erythematosus.
    Travers RL; Hughes GR
    J Rheumatol; 1978; 5(4):448-51. PubMed ID: 310887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [P-pills and rheumatism].
    Ostensen M; Husby G
    Tidsskr Nor Laegeforen; 1980 Feb; 100(5):301-2. PubMed ID: 7385159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of hormonal contraception on the course of lupus nephropathy].
    Jungers P; Dougados M; Pélissier C; Kuttenn F; Tron F; Pertuiset N; Bach JF
    Nouv Presse Med; 1982 Dec; 11(51):3765-8. PubMed ID: 7155880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of estrogen on the blast transformation of lymphocytes and interleukin-2 production in lupus erythematosus].
    Pozsonyi T; Jakab L; Jakab L; Onody K; Cseh K; Kalabay L
    Orv Hetil; 1992 May; 133(19):1167-71. PubMed ID: 1584598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
    Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
    Lemay A; Dewailly SD; Grenier R; Huard J
    J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contraception and pregnancy in systemic lupus erythematosus].
    Gompel A; Blétry O
    Rev Prat; 1990 Sep; 40(21):1946-51. PubMed ID: 2237188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cutaneous effects in hormonal contraception].
    Thomas P; Dalle E; Revillon B; Delecour M; Devarenne-nicolle MF; Pagniez I
    NPN Med; 1985 Jan; 5(81):19-24. PubMed ID: 12281276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraceptive-induced lupus erythematosus in a Japanese woman.
    Furukawa F; Tachibana T; Imamura S; Tamura T
    J Dermatol; 1991 Jan; 18(1):56-8. PubMed ID: 2050910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.
    Zaki K; Kamal I; Talaat MM; Rashad S; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):41-65. PubMed ID: 12256027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing female-based contraceptive methods in patients with systemic lupus erythematosus, rheumatoid arthritis and a healthy population.
    Dalkilic E; Tufan AN; Oksuz MF; Sahbazlar M; Coskun BN; Seniz N; Pehlivan Y; Inanc M
    Int J Rheum Dis; 2014 Jul; 17(6):653-7. PubMed ID: 24673794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shingles, allergies, family medical history, oral contraceptives, and other potential risk factors for systemic lupus erythematosus.
    Strom BL; Reidenberg MM; West S; Snyder ES; Freundlich B; Stolley PD
    Am J Epidemiol; 1994 Oct; 140(7):632-42. PubMed ID: 7942763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptives and systemic lupus erythematosus.
    Petri M; Robinson C
    Arthritis Rheum; 1997 May; 40(5):797-803. PubMed ID: 9153538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
    Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
    Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H
    Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.